Weitkamp Robin Joseph 4

What Happened

• Robin Joseph Weitkamp, Vice President & GM, Surfactants-International at Stepan Company, was granted equity awards on 2026-04-13 totaling 8,318 contingent shares. The filing reports three derivative awards of 2,859, 4,030 and 1,429 units, each recorded at $0.00 (award/grant transactions rather than open-market purchases or sales).

Key Details

• Transaction date: 2026-04-13; Form 4 filed: 2026-04-15 (filed within the typical two-business-day window).
• Award amounts: 2,859 + 4,030 + 1,429 = 8,318 units; reported price per unit = $0.00 (awards/grants).
• Nature of securities: These are contingent rights (derivative awards) — a mix of restricted stock units (RSUs) and performance shares per the filing footnotes.
  • RSUs: each RSU represents a contingent right to one share; RSUs vest ratably over three years beginning on the grant date.
  • Performance shares: each performance share represents a contingent right to one share; they vest only if company performance goals for the period ending 12/31/2028 are certified.
• Shares owned after the transaction: not specified in the information provided in this summary.
• Transaction code: A = Award/Grant (derivative awards). No sale, purchase, or option exercise reported.

Context

• These grants are compensation awards, not open-market purchases; they do not represent an immediate cash purchase or sale. RSUs typically convert to shares as they vest and become taxable; performance shares depend on future certification of goals, so actual shares received (if any) will depend on future performance results.
• Such awards are common for executives and generally reflect compensation/retention incentives rather than a direct statement of personal market sentiment.